A primigravida 32-year-old female is admitted to the antenatal ward at 35 weeks is found to BP of 160/110. Her urine does not contain albumin. Which of the following drugs should not be used in her management?
**Core Concept**
The patient is at risk of developing severe hypertension in pregnancy, specifically preeclampsia, characterized by high blood pressure and absence of significant proteinuria. Effective management involves careful selection of antihypertensive medications to ensure fetal safety.
**Why the Correct Answer is Right**
The patient is at risk of developing preeclampsia, a condition where the use of certain antihypertensive medications can be detrimental to the fetus. **Labetalol** and other beta-blockers are commonly used in preeclampsia due to their safety profile, but **hydralazine** is often used as a first-line agent in acute hypertension management in pregnancy. However, **methyldopa** is not typically used in acute settings due to its slower onset of action and potential for maternal side effects. **Nifedipine**, a calcium channel blocker, is also used in preeclampsia management.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because **Labetalol** is commonly used in preeclampsia management due to its safety profile for both mother and fetus.
**Option C:** This option is incorrect because **Hydralazine** is often used as a first-line agent in acute hypertension management in pregnancy.
**Option D:** This option is incorrect because **Nifedipine** is used in preeclampsia management, although it may be used with caution.
**Clinical Pearl / High-Yield Fact**
In managing hypertension in pregnancy, it's essential to remember that the primary goal is to prevent maternal complications while minimizing risks to the fetus. The choice of antihypertensive medication should be based on the severity of hypertension and the gestational age of the fetus.
**Correct Answer:** A. Methyldopa.